Search Results 61-70 of 16059 for pharmacogenetics
The purpose of this study is to: To evaluate whether the genotypic and phenotypic results for a single subject are the same among companies offering ...
... pharmacogenetic guidelines for psychiatry. MEDIA CONTACT: Bob Nellis, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu. These comments are ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy. Terri Malloy. August 25 ...
This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...
The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...
Read frequently asked questions and answers about genetic testing and genetic testing results from the Mayo Clinic Center for Individualized Medicine.
... 2007; U.S. Patent No. 7026163 — Sulfotransferase Sequence Variants, 2006; Member — American Medical Informatics Association, Clinical Pharmacogenetics ...
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
In this procedure, specialists aim to fix or replace a faulty gene to try to cure a disease or make the body better able to fight a disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.